Related Experiment Videos
Antiinflammatory and analgesic activity of CP-96,345: an orally active non-peptide substance P receptor antagonist
1Department of Medicinal Biology, Pfizer Inc., Aichi, Japan.
Regulatory Peptides
|July 2, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A High-End Estimate of Sea Level Rise for Practitioners.
Earth's future·2023
Evaluation of vegetable protein in canine diets: Assessment of performance and apparent ileal amino acid digestibility using a broiler model.
Journal of animal physiology and animal nutrition·2017
Pharmacology of grapiprant, a novel EP4 antagonist: receptor binding, efficacy in a rodent postoperative pain model, and a dose estimation for controlling pain in dogs.
Journal of veterinary pharmacology and therapeutics·2016
Modelling the increased frequency of extreme sea levels in the Ganges-Brahmaputra-Meghna delta due to sea level rise and other effects of climate change.
Environmental science. Processes & impacts·2015
The effects of climate change on storm surges around the United Kingdom.
Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2005
Predictions of extreme precipitation and sea-level rise under climate change.
Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2003
Hot off the Press.
Natural product reports·2026
Cytotoxic Dihydroagarofuran Sesquiterpenoids Isolated From the Roots of Tripterygium wilfordii.
Chemistry & biodiversity·2026
Crystal structures of new psychoactive substances 4-HO-DET and 4-AcO-DET.
Acta crystallographica. Section E, Crystallographic communications·2026
Development of dual SST2/SST5 targeting radioligands through rational structural design.
RSC medicinal chemistry·2026
Crosstalk between strigolactone and KAI2/KL signalling in plant growth and stress responses.
Frontiers in plant science·2026
AI-guided ethnopharmacology for cardiovascular drug discovery: from biomedical data to experimental validation.
Frontiers in pharmacology·2026